Vaccine development and testing generally takes several years, but time is not a luxury during a pandemic. Anthony S. Fauci, NIAID Director has stressed the fact that finding a safe and effective SARS-CoV-2 vaccine is an urgent public health priority right now and launching the first phase of the vaccine clinical trial in record speed stands as the first step in achieving this goal. The first phase of the clinical trial already took off on March 16th, 2020 and it is evidence of the giant leap scientists have taken in the clinical phase of the vaccine.
Pharma companies and biological laboratories are literally on the front line of the battlefield fighting an invisible enemy and Windward reporting software is proud to be associated with some of the top vaccine and drug-making companies. We can help automate your clinical trial reports. We’re here to play a small yet essential role in your effort to find a vaccine that can save millions of lives.
Our reporting software takes away the burden of creating simple or even complex clinical study reports. Individual scientists and researchers in your lab can design templates (without any need for coding or developer) right within popular platforms like MS Office (Excel, Word, and PowerPoint) and connect with one or various data sources to the template. They can use conditional logic and tags to customize different types of clinical study reports and generate them in just a couple of clicks.
Whether it’s during the registry of the first phase of the clinical trial where you have to include a lot of complex parameters and fields in the reports to choose a handful of candidates by scrutinizing hundreds of them or the third stage of the clinical trial where thousands of humans are involved and you need to assess the safety of the vaccine, you can count on Windward.
Windward reporting generation software can help speed up your SARS-CoV-2 vaccine research and approval by generating all types of reports (case report forms, adverse event reports and more) in this crucial life-saving endeavor at lightning speed with accuracy. Even after the vaccine is approved and released and you want to go ahead with phase four trials (to ensure the efficacy of the vaccine) that may involve tens of thousands of participants, you can count on Windward for swift report generation and sharing with other peers in your field in a wide range of output formats (PDF, Excel, Word, and more).
Let Windward take care of the routine clinical trial reports process while you are on an exceptional mission to save lives by coming up with an effective SARS-CoV-2 vaccine.